Slow-K
Natural health product licensed in Canada
- Licence holder
- Novartis Pharmaceuticals Canada Inc.
- NPN or DIN-HM
- 80040226
- Status
- Inactive licence
- Licence date
- 21 February 2013
- Revision date
- 31 March 2016
- Form
- Dragée
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Talc, Sucrose, Gélatine, Dioxyde de titanium, acacia, Alcool cétostéarylique, Stéarate de magnésium, Cire de Carnauba, Oxyde de fer (Fe2O3), Oxyde de Fer Jaune
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 5 Comprimé ; maximum: 12 Comprimé | 1 Tous les jours |
| Adultes | Not specified | minimum: 2 Comprimé ; maximum: 3 Comprimé | 1 Tous les jours |
| Adultes | Not specified | minimum: 2 Comprimé ; maximum: 6 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Treatment of potassium depletion in patients with hypokalemia and metabolic alkalosis. Helps to Prevent potassium deficiency due to low dietary intake. Helps to prevent potassium deficiency (hypokalemia) not resulting from a dietary deficiency
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80040226
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2016. Photograph the packaging to check whether it has changed. Photograph the packaging